Kyriazi Theo Melas, Director at Kaleido Biosciences, Inc. (KLDO), bought 66,666 shares at $7.50 ($500K) on 2020-06-04, disclosed to the SEC on 2020-06-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.50 | 33,333 | $250K | 50.0% |
| 2 | $7.50 | 33,333 | $250K | 50.0% |
| Total | $7.50 avg | 66,666 | $500K | 100% |
| Filing → |